Receiving Acute Care For Hallucinogen Use Linked With Greater 5-Year Mortality Risk, Study Finds

Healio (3/20, Mahoney ) reports a study found that “individuals in Canada who received hospital care for hallucinogen use had greater 5-year mortality risk, especially from suicide, compared with the general population.” Researchers determined that, “compared with the matched general population, the hallucinogen group appeared more likely to live in low-income neighborhoods, have several chronic conditions, and have received outpatient mental health care or acute care for substance use or a mental disorder in the past 3 years.” Furthermore, “a greater proportion of individuals in the hallucinogen group died” within five years “compared with the general population group (6.1% vs. 0.6%), equating to a 9.7-fold greater increase.” Based on the results, the researchers “theorized that hallucinogen use in vulnerable people in nonmedical settings may increase suicide risk or lead to the development of severe mental illnesses.” The study was published in the Canadian Medical Association Journal.

Related Links:

— “Receipt of acute care for hallucinogen use predicts greater mortality risk within 5 years,” Moira Mahoney, Healio, March 20, 2025

Posted in In The News.